Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists test new vaccine to protect pregnant women from deadly malaria

NCT ID NCT02471378

Summary

This study aims to develop a vaccine that prevents malaria infection during pregnancy, which poses serious risks to both mothers and babies. Researchers are testing potential vaccine candidates using laboratory tests with malaria parasites collected from pregnant women in Mali. The study involves collecting blood samples from up to 7,476 pregnant women to evaluate how well the vaccine candidates might work compared to natural immunity.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALARIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ouelessebougou Clinical Research Center

    RECRUITING

    Bamako, Mali

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.